BRWM
ATNM icon

B. Riley Wealth Management’s Actinium Pharmaceuticals ATNM Stock Holding History

B. Riley Wealth Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-200
Closed -$1K – 405
2019
Q3 		$1K Buy
+200
New +$1.39K ﹤0.01% 393

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

B. Riley Wealth Management's ATNM Position: Q4 2019 in Review

B. Riley Wealth Management sold out of Actinium Pharmaceuticals (ATNM) in Q4 2019, closing a stake of 200 shares — an estimated $1K sold.

B. Riley Wealth Management first reported a position in ATNM in Q3 2019 and held it in 1 quarter. The position peaked at $1K in Q3 2019. 45 funds tracked by Wall St. Rank hold ATNM as of Q4 2019.

  • B. Riley Wealth Management reported no remaining Actinium Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • B. Riley Wealth Management sold 200 Actinium Pharmaceuticals shares in Q4 2019, an estimated $1K.
  • B. Riley Wealth Management first reported a position in Actinium Pharmaceuticals in Q3 2019 and held it in 1 quarter.
  • B. Riley Wealth Management's Actinium Pharmaceuticals position peaked at $1K in Q3 2019.
  • 45 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2019.

Based on B. Riley Wealth Management's 13F filing for Q4 2019, filed 14 Feb 2020.